GFAP and proteostasis deficiencies: In addition to the emergence of compound proteinopathies in wide brain regions, we performed IHC with antibodies specific for Iba1, GFAP and TNFα to assess the extent of gliosis and neuroinflammation, which are key features in neurodegenerative diseases39,40.